A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.
Public ClinicalTrials.gov record NCT00147589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Peds I (Pediatric Eplerenone Development Study I): A Randomized, Double-Blind, Placebo Withdrawal, Parallel Group, Dose-Response Study To Evaluate The Efficacy And Safety Of Eplerenone In The Treatment Of Hypertension In Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and about 320 patients will participate.
Study identification
- NCT ID
- NCT00147589
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Jan 2007 (Actual)
- Last update posted
- Dec 22, 2020
2004 – 2007
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Beverly Hills | California | — | — |
| Pfizer Investigational Site | Inglewood | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Jacksonville | Florida | — | — |
| Pfizer Investigational Site | Miami | Florida | — | — |
| Pfizer Investigational Site | Augusta | Georgia | — | — |
| Pfizer Investigational Site | Park Ridge | Illinois | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Shreveport | Louisiana | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | — | — |
| Pfizer Investigational Site | Jackson | Mississippi | — | — |
| Pfizer Investigational Site | Tupelo | Mississippi | — | — |
| Pfizer Investigational Site | Livingston | New Jersey | — | — |
| Pfizer Investigational Site | Carrboro | North Carolina | — | — |
| Pfizer Investigational Site | Chapel Hill | North Carolina | — | — |
| Pfizer Investigational Site | Pittsboro | North Carolina | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Columbus | Ohio | — | — |
| Pfizer Investigational Site | Youngstown | Ohio | — | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | — | — |
| Pfizer Investigational Site | Memphis | Tennessee | — | — |
| Pfizer Investigational Site | Beaumont | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | Katy | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00147589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2020 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00147589 live on ClinicalTrials.gov.